本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ADC Therapeutics SA

1.07
-0.0400-3.60%
盤後1.070.00000.00%19:30 EDT
成交量:98.91萬
成交額:105.45萬
市值:1.36億
市盈率:-1.47
高:1.16
開:1.13
低:1.04
收:1.11
52周最高:4.98
52周最低:0.7796
股本:1.27億
流通股本:8,856.21萬
量比:0.63
換手率:1.12%
股息:- -
股息率:- -
每股收益(TTM):-0.7271
每股收益(LYR):-1.1224
淨資產收益率:-705.53%
總資產收益率:-19.57%
市淨率:-0.60
市盈率(LYR):-0.95

資料載入中...

2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/21

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/09/14

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/05/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/14

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/12

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/12

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/11

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/28

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/04/24

招股説明書

F-1 - Registration statement for certain foreign private issuers
2019/10/03

SEC問詢函

CORRESP [Cover] - Correspondence
2019/09/30

SEC問詢函

CORRESP [Cover] - Correspondence